|
CH449645A
(de)
|
1963-07-09 |
1968-01-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer Aminosäuren
|
|
JPS4940460Y2
(cg-RX-API-DMAC10.html)
|
1971-05-19 |
1974-11-06 |
|
|
|
US4087544A
(en)
|
1974-12-21 |
1978-05-02 |
Warner-Lambert Company |
Treatment of cranial dysfunctions using novel cyclic amino acids
|
|
DE2460891C2
(de)
|
1974-12-21 |
1982-09-23 |
Gödecke AG, 1000 Berlin |
1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US4123438A
(en)
|
1975-03-05 |
1978-10-31 |
Stamicarbon, B.V. |
Process for preparing 2-pyrrolidones
|
|
NZ194348A
(en)
|
1979-07-26 |
1982-09-14 |
Merrell Toraude & Co |
Fluorinated methyl-beta-alanine derivatives and pharmaceutical compositions
|
|
US4322440A
(en)
|
1980-06-25 |
1982-03-30 |
New York University |
Anticonvulsive compositions and method of treating convulsive disorders
|
|
US4513135A
(en)
|
1982-03-05 |
1985-04-23 |
Eli Lilly And Company |
Diaryl-pyrazine derivatives affecting GABA binding
|
|
DK373383A
(da)
|
1982-08-20 |
1984-02-21 |
Midit |
Fremgangsmaade til fremstilling af omega-aminosyrederivater
|
|
US4479005A
(en)
|
1982-12-16 |
1984-10-23 |
The Dow Chemical Company |
Selective preparation of isomers and enantiomers of cyclopropane carboxylic acids
|
|
DE133795T1
(de)
|
1983-08-01 |
1985-09-12 |
The Mclean Hospital Corp., Belmont, Mass. |
Gaba-ester und gaba-analoge ester.
|
|
US5051448A
(en)
|
1984-07-24 |
1991-09-24 |
The Mclean Hospital Corporation |
GABA esters and GABA analog esters
|
|
GB8425872D0
(en)
|
1984-10-12 |
1984-11-21 |
Ciba Geigy Ag |
Chemical compounds
|
|
NO166131C
(no)
|
1985-06-20 |
1991-06-05 |
Daiichi Seiyaku Co |
Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.
|
|
US4956388A
(en)
|
1986-12-22 |
1990-09-11 |
Eli Lilly And Company |
3-aryloxy-3-substituted propanamines
|
|
JP2535001B2
(ja)
|
1987-01-13 |
1996-09-18 |
ダイセル化学工業株式会社 |
Ｎ−アルキル化アミノ酸エステルの製法
|
|
JPH07116064B2
(ja)
|
1987-07-21 |
1995-12-13 |
三菱化学株式会社 |
分離剤
|
|
US4908210A
(en)
|
1988-10-28 |
1990-03-13 |
Eastman Kodak Company |
Lactylic salt tablet formulations and tablets
|
|
GB8911017D0
(en)
|
1989-05-13 |
1989-06-28 |
Ciba Geigy Ag |
Substituted aminoalkylphosphinic acids
|
|
DE3928183A1
(de)
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Lactamfreie cyclische aminosaeuren
|
|
GB8921304D0
(en)
|
1989-09-20 |
1989-11-08 |
Wyeth John & Brother Ltd |
New method of treatment and heterocyclic compounds used therein
|
|
US5104869A
(en)
|
1989-10-11 |
1992-04-14 |
American Cyanamid Company |
Renin inhibitors
|
|
US5084479A
(en)
|
1990-01-02 |
1992-01-28 |
Warner-Lambert Company |
Novel methods for treating neurodegenerative diseases
|
|
US5025035A
(en)
|
1990-10-12 |
1991-06-18 |
Warner-Lambert Company |
Method of treating depression
|
|
AU9137091A
(en)
*
|
1990-11-27 |
1992-06-25 |
Northwestern University |
Gaba and l-glutamic acid analogs for antiseizure treatment
|
|
US6197819B1
(en)
|
1990-11-27 |
2001-03-06 |
Northwestern University |
Gamma amino butyric acid analogs and optical isomers
|
|
WO1992014443A1
(en)
|
1991-02-20 |
1992-09-03 |
Warner-Lambert Company |
Microsphere-in-oil emulsion
|
|
DK204791D0
(da)
|
1991-12-20 |
1991-12-20 |
Novo Nordisk As |
Hidtil ukendt farmaceutisk praeparat
|
|
ES2165857T3
(es)
|
1992-05-20 |
2002-04-01 |
Univ Northwestern |
Analogos de gaba y acido l-glutamico para el tratamiento de trastornos del sistema nervioso central.
|
|
GB9308430D0
(en)
|
1993-04-23 |
1993-06-09 |
Glaxo Group Ltd |
Medicaments
|
|
US5492927A
(en)
|
1993-12-21 |
1996-02-20 |
Eli Lilly And Company |
Non-peptide tachykinin receptor antagonists to treat allergy
|
|
US5652216A
(en)
|
1994-05-26 |
1997-07-29 |
Novo Nordisk A/S |
Pharmaceutical preparation
|
|
EP0804182B1
(en)
|
1994-07-27 |
2002-06-05 |
Warner-Lambert Company |
Use of gabapentin in the treatment of anxiety and panic
|
|
US5792796A
(en)
|
1994-07-27 |
1998-08-11 |
Warner-Lambert Company |
Methods for treating anxiety and panic
|
|
GB9420784D0
(en)
|
1994-10-14 |
1994-11-30 |
Glaxo Group Ltd |
Medicaments
|
|
US5767117A
(en)
|
1994-11-18 |
1998-06-16 |
The General Hospital Corporation |
Method for treating vascular headaches
|
|
EP0802912B1
(en)
|
1995-01-12 |
2004-10-13 |
Glaxo Group Limited |
Piperidine derivatives having tachykinin antagonist activity
|
|
EA000380B1
(ru)
|
1995-02-28 |
1999-06-24 |
Х.Лундбекк А/С |
4-аминотетрагидробензизоксазоловые или -изотиазоловые соединения, их применение и фармацевтическая композиция на их основе
|
|
US5510381A
(en)
|
1995-05-15 |
1996-04-23 |
Warner-Lambert Company |
Method of treatment of mania and bipolar disorder
|
|
US5616793A
(en)
|
1995-06-02 |
1997-04-01 |
Warner-Lambert Company |
Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
|
|
US5637767A
(en)
|
1995-06-07 |
1997-06-10 |
Warner-Lambert Company |
Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
|
|
EP0888325B1
(en)
|
1996-02-07 |
2002-05-29 |
Warner-Lambert Company |
Novel cyclic amino acids as pharmaceutical agents
|
|
IL125364A0
(en)
|
1996-03-14 |
1999-03-12 |
Warner Lambert Co |
Novel bridged cyclic amino acids and pharmaceutical compositions containing them
|
|
KR100512506B1
(ko)
|
1996-03-14 |
2005-12-21 |
워너-램버트 캄파니 엘엘씨 |
제약제제로서신규한치환시클릭아미노산
|
|
US20020077461A1
(en)
|
1996-04-24 |
2002-06-20 |
Soren Bjorn |
Pharmaceutical formulation
|
|
US6372792B1
(en)
|
1996-04-26 |
2002-04-16 |
Guy Chouinard |
Method for treating anxiety, anxiety disorders and insomnia
|
|
WO1997049393A1
(en)
|
1996-06-26 |
1997-12-31 |
Warner-Lambert Company |
Use of a tachykinin antagonist for the manufacture of a medicament for the treatment of emesis
|
|
SE9603408D0
(sv)
|
1996-09-18 |
1996-09-18 |
Astra Ab |
Medical use
|
|
HRP980342A2
(en)
|
1997-06-25 |
1999-02-28 |
Warner Lambert Co |
Anti-inflammatory method
|
|
US6329429B1
(en)
|
1997-06-25 |
2001-12-11 |
Warner-Lambert Company |
Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
|
|
WO1999008667A2
(en)
|
1997-08-19 |
1999-02-25 |
Warner-Lambert Company |
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
|
|
WO1999008670A1
(en)
|
1997-08-20 |
1999-02-25 |
Guglietta, Antonio |
Gaba analogs to prevent and treat gastrointestinal damage
|
|
US6127418A
(en)
|
1997-08-20 |
2000-10-03 |
Warner-Lambert Company |
GABA analogs to prevent and treat gastrointestinal damage
|
|
ES2253825T3
(es)
|
1997-09-08 |
2006-06-01 |
Warner-Lambert Company Llc |
Composiciones analgesicas que comprenden compuestos antiepilepticos y procedimientos para usar las mismas.
|
|
JP2002508361A
(ja)
|
1997-12-16 |
2002-03-19 |
ワーナー−ランバート・カンパニー |
（（シクロ）アルキル置換）−γ−アミノ酪酸誘導体（＝ＧＡＢＡ類似体）、それらの製造および神経学的疾患の治療における使用
|
|
CN1303991C
(zh)
|
1998-05-15 |
2007-03-14 |
沃尼尔·朗伯公司 |
γ－氨基丁酸衍生物的稳定药物制剂和其制备方法
|
|
CU23051A3
(es)
|
1998-05-15 |
2005-06-24 |
Warner Lambert Co |
Composiciones solidas que contienen derivados de acido gamma-aminobutirico y procesos para prepararlas.
|
|
KR20010071777A
(ko)
|
1998-07-09 |
2001-07-31 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
Ｇａｂａ 유사체 및 카페인을 포함하는 조성물
|
|
US6680343B1
(en)
|
1998-07-09 |
2004-01-20 |
Warner-Lambert Comapny |
Treatment of renal colic with GABA analogs
|
|
US20030045500A1
(en)
|
1998-07-09 |
2003-03-06 |
Leslie Magnus |
Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
|
|
CA2333024C
(en)
|
1998-07-09 |
2002-03-26 |
Warner-Lambert Company |
Method for the treatment of insomnia
|
|
CA2344407C
(en)
|
1998-10-16 |
2007-01-09 |
Warner-Lambert Company |
Method for the treatment of mania and bipolar disorder
|
|
AU3216600A
(en)
|
1999-03-10 |
2000-09-28 |
Warner-Lambert Company |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
|
|
US6992109B1
(en)
|
1999-04-08 |
2006-01-31 |
Segal Catherine A |
Method for the treatment of incontinence
|
|
EP1180058A1
(en)
|
1999-04-09 |
2002-02-20 |
Warner-Lambert Company |
Combinations of gaba analogs and tricyclic compounds to treat depression
|
|
JP2003525207A
(ja)
|
1999-06-02 |
2003-08-26 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
薬剤として有用なアミノ複素環
|
|
US6642398B2
(en)
|
1999-06-10 |
2003-11-04 |
Warner-Lambert Company |
Mono-and disubstituted 3-propyl gamma-aminobutyric acids
|
|
US7164034B2
(en)
|
1999-06-10 |
2007-01-16 |
Pfizer Inc. |
Alpha2delta ligands for fibromyalgia and other disorders
|
|
ES2255500T3
(es)
|
1999-07-02 |
2006-07-01 |
Warner-Lambert Company Llc |
Combinacion simergica. gabapentina y pregabalina.
|
|
US7030119B1
(en)
|
1999-07-16 |
2006-04-18 |
Warner-Lambert Company |
Method for treating chronic pain using MEK inhibitors
|
|
JP2003512602A
(ja)
|
1999-09-16 |
2003-04-02 |
ワーナー−ランバート・カンパニー |
α２δ−１サブユニット結合リガンドのスクリーニング方法
|
|
AP2002002501A0
(en)
|
1999-10-07 |
2002-06-30 |
Warner Lambert Co |
Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
|
|
NZ519551A
(en)
|
2000-01-27 |
2004-02-27 |
Warner Lambert Co |
Asymmetric synthesis of pregabalin
|
|
US20010036943A1
(en)
|
2000-04-07 |
2001-11-01 |
Coe Jotham W. |
Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
|
|
WO2001088101A2
(en)
|
2000-05-16 |
2001-11-22 |
Warner-Lambert Company |
CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT
|
|
GB2365425A
(en)
|
2000-08-01 |
2002-02-20 |
Parke Davis & Co Ltd |
Alkyl amino acid derivatives useful as pharmaceutical agents
|
|
CA2356829A1
(en)
|
2000-09-22 |
2002-03-22 |
Warner-Lambert Company |
Method for treating asthma using pregabalin
|
|
US6620829B2
(en)
|
2000-10-17 |
2003-09-16 |
Warner-Lambert Company |
Method of treating noninflammatory cartilage damage
|
|
CN1477976A
(zh)
|
2000-11-30 |
2004-02-25 |
�Ʒ� |
Gaba激动剂与醛糖还原酶抑制剂的组合
|
|
PL365927A1
(en)
|
2000-11-30 |
2005-01-10 |
Pfizer Products Inc. |
Combination of gaba agonists and sorbitol dehydrogenase inhibitors
|
|
ATE291028T1
(de)
|
2000-12-13 |
2005-04-15 |
Warner Lambert Co |
P-chirale bisphospholane ligande, deren übergangsmetall-komplexe
|
|
US20040002543A1
(en)
|
2001-02-16 |
2004-01-01 |
Leslie Magnus |
Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain
|
|
ATE297902T1
(de)
|
2001-02-28 |
2005-07-15 |
Pfizer Prod Inc |
Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren
|
|
MXPA02001147A
(es)
|
2001-03-19 |
2004-04-21 |
Warner Lambert Co |
Sintesis de ligandos bisfosina no-c2-simetricos como catalizadores para la hidrogenacion asimetrica.
|
|
EP1247809A3
(en)
|
2001-03-30 |
2003-12-17 |
Pfizer Products Inc. |
Triazine compounds useful as sorbitol dehydrogenase inhibitors
|
|
US7022678B2
(en)
|
2001-03-30 |
2006-04-04 |
Warner-Lambert Company |
Pregabalin lactose conjugates
|
|
AU2002226634B2
(en)
|
2001-03-30 |
2007-01-25 |
Pfizer Products Inc. |
Pyridazinone aldose reductase inhibitors
|
|
TNSN03094A1
(fr)
|
2001-04-19 |
2005-12-23 |
Warner Lambert Co |
Amino-acides condenses bicycliques ou tricycliques
|
|
MXPA03009392A
(es)
|
2001-05-25 |
2004-01-29 |
Warner Lambert Co |
Composicion famaceutica liquida.
|
|
US20030045449A1
(en)
|
2001-08-15 |
2003-03-06 |
Pfizer, Inc. |
Pharmaceutical combinations for the treatment of neurodegenerative diseases
|
|
DE10203122A1
(de)
|
2002-01-25 |
2003-07-31 |
Gruenenthal Gmbh |
Verfahren zur Herstellung von substituierten Acrylsäureestern bzw. deren Einsatz zur Herstellung von substituierten gamma-Aminosäuren
|
|
EP1469841A1
(en)
|
2002-01-31 |
2004-10-27 |
Warner-Lambert Company |
Alpha 2 delta ligands to treat tinnitus
|
|
US6855724B2
(en)
|
2002-04-08 |
2005-02-15 |
Agouron Pharmaceuticals, Inc. |
Tropane derivatives useful in therapy
|
|
US6713490B2
(en)
|
2002-04-26 |
2004-03-30 |
Pfizer, Inc. |
3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
|
|
US20030225149A1
(en)
|
2002-04-30 |
2003-12-04 |
Blazecka Peter G. |
Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
|
|
WO2004002462A2
(en)
|
2002-06-27 |
2004-01-08 |
Warner-Lambert Company Llc |
Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
|
|
EP1521733B1
(en)
|
2002-07-08 |
2014-08-20 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
|
US7053122B2
(en)
|
2002-08-09 |
2006-05-30 |
Pfizer Inc |
Therapeutic use of aryl amino acid derivatives
|
|
US7419981B2
(en)
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
US20040092522A1
(en)
|
2002-08-15 |
2004-05-13 |
Field Mark John |
Synergistic combinations
|
|
US7071339B2
(en)
|
2002-08-29 |
2006-07-04 |
Warner Lambert Company Llc |
Process for preparing functionalized γ-butyrolactones from mucohalic acid
|
|
US7659305B2
(en)
|
2002-10-31 |
2010-02-09 |
Pfizer Inc. |
Therapeutic proline derivatives
|
|
CA2508601A1
(en)
|
2002-12-06 |
2004-06-24 |
Warner-Lambert Company Llc |
Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
KR100845932B1
(ko)
|
2002-12-13 |
2008-07-11 |
워너-램버트 캄파니 엘엘씨 |
섬유근육통 및 기타 관련 질환의 치료를 위한 프레가발린및 그의 유도체
|
|
US7572910B2
(en)
|
2003-02-20 |
2009-08-11 |
Pfizer, Inc. |
Pyridazinone aldose reductase inhibitors
|
|
AU2004237951A1
(en)
|
2003-05-16 |
2004-11-25 |
Pfizer Products Inc. |
Therapeutic combinations of atypical antipsychotics with GABA modulators, anticonvulsants or benzodiazapines
|
|
JP2006526605A
(ja)
|
2003-06-05 |
2006-11-24 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
治療剤としての３−置換インドール類及びそれらの誘導体
|
|
WO2005002585A1
(en)
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
|
GEP20084527B
(en)
|
2003-09-03 |
2008-11-10 |
Pfizer |
Benzimidazolone compounds having 5-ht4 receptor agonistic activity
|
|
KR20060087560A
(ko)
|
2003-09-12 |
2006-08-02 |
워너-램버트 캄파니 엘엘씨 |
알파-2-델타 리간드 및 ｓｓｒｉ 및/또는 ｓｎｒｉ를포함하는 우울증 및 불안 장애 치료용 조합물
|
|
WO2005025675A1
(en)
|
2003-09-12 |
2005-03-24 |
Pfizer Limited |
Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
|
|
GB0322140D0
(en)
|
2003-09-22 |
2003-10-22 |
Pfizer Ltd |
Combinations
|
|
MXPA06003396A
(es)
|
2003-09-25 |
2006-06-08 |
Warner Lambert Co |
Profarmacos de aminoacidos con afinidad por la proteina a 2d.
|
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
|
EP1543831A1
(en)
|
2003-12-18 |
2005-06-22 |
Pfizer GmbH Arzneimittelwerk Gödecke |
Pregabalin composition
|
|
WO2005082372A1
(en)
|
2004-01-29 |
2005-09-09 |
Pfizer Products Inc. |
COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS
|
|
GB0405200D0
(en)
|
2004-03-08 |
2004-04-21 |
Pfizer Ltd |
Combinations comprising alpha-2-delta ligands
|
|
PT1727620E
(pt)
|
2004-03-12 |
2007-11-05 |
Warner Lambert Co |
Ligandos de biofosfina c1-simétricos e a sua utilização na síntese assimétrica da pregabalina
|
|
JP2007530656A
(ja)
|
2004-03-29 |
2007-11-01 |
ファイザー株式会社 |
ＯＲＬ１受容体拮抗薬としてのαアリールまたはヘテロアリールメチルβピペリジノプロパンアミド化合物
|
|
EP1735324B1
(en)
|
2004-04-01 |
2008-08-20 |
Warner-Lambert Company LLC |
Preparation of p-chirogenic phospholanes and their use in asymetric synthesis
|
|
BRPI0509731A
(pt)
|
2004-04-07 |
2007-09-25 |
Pfizer |
pirazol[4,3-d]pirimidinas
|
|
UA82292C2
(uk)
|
2004-04-14 |
2008-03-25 |
Пфайзер Продактс Инк. |
Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
|
|
US20090170897A1
(en)
|
2004-04-20 |
2009-07-02 |
Pfizer, Inc. |
Method of Treating Neuropathic Pain
|
|
CN1946391A
(zh)
|
2004-04-20 |
2007-04-11 |
辉瑞产品公司 |
包含α－2－δ配体的组合
|
|
WO2005102390A2
(en)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
|
|
BRPI0510453A
(pt)
|
2004-04-30 |
2007-10-30 |
Warner Lambert Co |
composto substituìdos com morfolina para o tratamento de distúrbios do sistema nervoso central
|
|
KR100875558B1
(ko)
|
2004-06-15 |
2008-12-23 |
화이자 인코포레이티드 |
벤즈이미다졸론 카복실산 유도체
|
|
US7737163B2
(en)
|
2004-06-15 |
2010-06-15 |
Pfizer Inc. |
Benzimidazolone carboxylic acid derivatives
|
|
EA011765B1
(ru)
|
2004-06-21 |
2009-06-30 |
УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си |
Получение прегабалина и родственных соединений
|
|
RU2006146675A
(ru)
|
2004-06-29 |
2008-07-10 |
Пфайзер Продактс Инк. (Us) |
Способ получения производных 5-[4-(2-гидроксипропил)-3,5-диоксо-4,5-дигидро-3н-[1,2,4] триазин-2-ил] бензамида снятием защиты с промежуточных продуктов, содержащих защищенный гидроксил
|
|
US20060003344A1
(en)
|
2004-06-30 |
2006-01-05 |
Pfizer Inc. |
Methods related to a single nucleotide polymorphism of the G protein coupled receptor, GPR40
|
|
WO2006008640A1
(en)
|
2004-07-15 |
2006-01-26 |
Pharmacia & Upjohn Company Llc |
Non-aqueous suspension containing a drug having an unpleasant taste
|
|
BRPI0513717A
(pt)
|
2004-07-23 |
2008-05-13 |
Pfizer |
derivados de piridina
|
|
GB0419849D0
(en)
|
2004-09-07 |
2004-10-13 |
Pfizer Ltd |
Pharmaceutical combination
|
|
ATE417830T1
(de)
|
2004-11-02 |
2009-01-15 |
Pfizer |
Sulfonylbenzimidazolderivate
|
|
CN101087771A
(zh)
|
2004-11-10 |
2007-12-12 |
辉瑞大药厂 |
经取代n－磺酰基氨基苄基－2－苯氧基乙酰胺化合物
|
|
US7122683B2
(en)
|
2004-11-23 |
2006-10-17 |
Pfizer Inc. |
Amides useful as monoamine re-uptake inhibitors
|
|
ATE460415T1
(de)
|
2004-11-29 |
2010-03-15 |
Warner Lambert Co |
Therapeutische pyrazoloä3,4-büpyridine und - indazole
|
|
ES2366375T3
(es)
|
2005-02-22 |
2011-10-19 |
Pfizer, Inc. |
Derivados de oxiindol, como agonistas del receptor 5-ht4.
|
|
WO2006092692A1
(en)
|
2005-03-01 |
2006-09-08 |
Pfizer Limited |
Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
|
|
EP1858865B1
(en)
|
2005-03-10 |
2009-09-16 |
Pfizer Inc. |
Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
|
|
EP1861359B1
(en)
|
2005-03-17 |
2012-11-14 |
Pfizer Inc. |
N-(n-sulfonylaminomethyl)cyclopropanecarboxamide derivatives useful for the treatment of pain
|
|
CA2604218A1
(en)
|
2005-04-20 |
2006-10-26 |
Pfizer Limited |
Pyrazole derivatives as progesterone receptor antagonists
|
|
JP4173909B1
(ja)
|
2005-04-28 |
2008-10-29 |
ファイザー・リミテッド |
アミノ酸誘導体
|
|
WO2006123247A2
(en)
|
2005-05-20 |
2006-11-23 |
Pfizer Limited |
Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
|
|
ES2382876T3
(es)
|
2005-05-31 |
2012-06-14 |
Pfizer, Inc. |
Compuestos de ariloxi-N-biciclometil-acetamida sustituidos como antagonistas de VR1
|
|
NL2000281C2
(nl)
|
2005-11-02 |
2007-08-07 |
Pfizer Prod Inc |
Vaste farmaceutische samenstellingen die pregabaline bevatten.
|
|
NL2000284C2
(nl)
|
2005-11-04 |
2007-09-28 |
Pfizer Ltd |
Pyrazine-derivaten.
|
|
PL1948615T3
(pl)
|
2005-11-08 |
2012-04-30 |
Pfizer Ltd |
Pochodne pirazolu przydatne w leczeniu chorób ginekologicznych
|
|
MEP0408A
(xx)
|
2005-12-02 |
2010-02-10 |
Pfizer Ltd |
Derivati hinociklicnog hinazolina kao inhibitori pde7
|
|
CA2530904C
(en)
|
2005-12-20 |
2013-10-08 |
John Marino |
Pharmaceutical agents for the treatment of pain associated with spinal cord injury
|
|
EP1993529A1
(en)
|
2006-03-06 |
2008-11-26 |
Pfizer Products Inc. |
Alpha-2-delta ligands for non-restorative sleep
|
|
GB0700786D0
(en)
|
2007-01-15 |
2007-02-21 |
Pfizer Ltd |
Morpholine dopamine agonists for the treatment of pain
|
|
UA94639C2
(ru)
|
2007-02-02 |
2011-05-25 |
Пфайзер Продактс Інк. |
Трициклические соединения и их применение как модуляторов глюкокортикоидного рецептора
|
|
WO2008132589A1
(en)
|
2007-05-01 |
2008-11-06 |
Pfizer Limited |
Combinations comprising pregabalin
|